Botanical species · safety record

Dorstenia contrajerva

The EFSA Compendium of Botanicals holds 6 constituent measurements for Dorstenia contrajerva. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Dorstenia contrajerva L.

6Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Bergapten	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Bergapten	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Bergaptol	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Furanocoumarins	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Cardenolides	Roots and other underground parts	Solvent extraction	—	IR and Raman Spectroscopy	No resolvable identifier
Furanocoumarins	Unspecified	—	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Caceres, A., Rastrelli, L., De Simone, F., De Martino, G., Saturnino, C., Saturnino, P., Aquino, R. Furanocoumarins from the aerial parts of Dorstenia contrajerva. FITOTERAPIA, 2001, vol. 72, no. 4, p. 376-381. DOI
Casagrande, C., Ronchetti, F., Russo, G. Structure of syriogenin. Tetrahedron, 1974, p. 3587-3589.
Santana, L., Uriarte, E., Roleira, F., Milhazes, N., Borges, F. Furocoumarins in medicinal chemistry. Synthesis, natural occurrence and biological activity. CURRENT MEDICINAL CHEMISTRY, 2004, vol. 11, no. 24, p. 3239-3261.
TERREAUX, C., MAILLARD, M., STOECKLIEVANS, H., GUPTA, MP., DOWNUM, KR., QUIRKE, JME., HOSTETTMANN, K. STRUCTURE REVISION OF A FURANOCOUMARIN FROM DORSTENIA-CONTRAJERVA. PHYTOCHEMISTRY, 1995, vol. 39, no. 3, p. 645-647. DOI
SWAIN, LA., QUIRKE, JME., WINKLE, SA., DOWNUM, KR. A FURANOCOUMARIN FROM DORSTENIA-CONTRAJERVA. PHYTOCHEMISTRY, 1991, vol. 30, no. 12, p. 4196-4197. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature